» Articles » PMID: 36745231

Current Standards of Surgical Management of Gastric Cancer: an Appraisal

Overview
Specialty General Surgery
Date 2023 Feb 6
PMID 36745231
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Gastric cancer (GC) is the fifth most common malignancy worldwide and portends a grim prognosis due to a lack of appreciable improvement in 5-year survival. We aimed to analyze the available literature and summarize the current standards of surgical care for curative and palliative intent treatment of GC.

Methods: We conducted a systematic search on the PubMed database for studies on the management of GC.

Results: Endoscopic resection is an acceptable treatment option for T1a tumors. The role of optimal resection margin for GC remains unclear. D2 lymph node dissection remains the standard of care with splenectomy needed selectively for splenic hilum involvement. A distal pancreatic resection should be avoided. The advantage of bursectomy and omentectomy in GC surgery is not clear. Multi-visceral resection may be considered for locally advanced GC in carefully selected patients. Minimally invasive approaches are non-inferior to open surgery. Surgery should be abandoned prior even in metastatic GC within the frame of multimodal therapy approach.

Conclusion: Various trials have conclusively shown improved patient outcomes when well-established surgical standards are followed.

References
1.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

2.
Stock M, Otto F . Gene deregulation in gastric cancer. Gene. 2005; 360(1):1-19. DOI: 10.1016/j.gene.2005.06.026. View

3.
Santucci C, Carioli G, Bertuccio P, Malvezzi M, Pastorino U, Boffetta P . Progress in cancer mortality, incidence, and survival: a global overview. Eur J Cancer Prev. 2020; 29(5):367-381. DOI: 10.1097/CEJ.0000000000000594. View

4.
Song M, Rabkin C, Camargo M . Gastric Cancer: an Evolving Disease. Curr Treat Options Gastroenterol. 2018; 16(4):561-569. PMC: 7453722. DOI: 10.1007/s11938-018-0203-1. View

5.
Moehler M, Baltin C, Ebert M, Fischbach W, Gockel I, Grenacher L . International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus. Gastric Cancer. 2014; 18(3):550-63. DOI: 10.1007/s10120-014-0403-x. View